MAP0010 low dose

DRUG3 trials

Sponsors

Allergan

Conditions

Asthma

Phase 1

Safety and Blood Level Study of Unit Dose Budesonide

CompletedNCT00627679

Start: 2005-12-31End: 2006-05-31Updated: 2014-01-09

Phase 2

A Study of 2 Doses of MAP0010 in Adult Asthmatics

CompletedNCT00554970

Start: 2007-11-30End: 2008-03-31Updated: 2014-01-09

Study of MAP0010 in Asthmatic Children and Adolescents

CompletedNCT00697801

Start: 2006-07-31End: 2006-12-31Updated: 2014-01-09